Correlation Between Axim Biotechnologies and Pharmala Biotech

Can any of the company-specific risk be diversified away by investing in both Axim Biotechnologies and Pharmala Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Axim Biotechnologies and Pharmala Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Axim Biotechnologies and Pharmala Biotech Holdings, you can compare the effects of market volatilities on Axim Biotechnologies and Pharmala Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Axim Biotechnologies with a short position of Pharmala Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Axim Biotechnologies and Pharmala Biotech.

Diversification Opportunities for Axim Biotechnologies and Pharmala Biotech

-0.25

Correlation Coefficient

Axim Biotechnologies  Pharmala Biotech

Very good diversification

The 3 months correlation between Axim and Pharmala is -0.25. Overlapping area represents the amount of risk that can be diversified away by holding Axim Biotechnologies and Pharmala Biotech Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pharmala Biotech Holdings and Axim Biotechnologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Axim Biotechnologies are associated (or correlated) with Pharmala Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pharmala Biotech Holdings has no effect on the direction of Axim Biotechnologies i.e., Axim Biotechnologies and Pharmala Biotech go up and down completely randomly.

Pair Corralation between Axim Biotechnologies and Pharmala Biotech

If you would invest  2.00  in Axim Biotechnologies on September 15, 2024 and sell it today you would lose (1.80) from holding Axim Biotechnologies or give up 90.0% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	0.4%
Values	Daily Returns

Axim Biotechnologies  vs.  Pharmala Biotech Holdings

Axim Biotechnologies

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Axim Biotechnologies are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of very weak forward indicators, Axim Biotechnologies displayed solid returns over the last few months and may actually be approaching a breakup point.

Pharmala Biotech Holdings

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Pharmala Biotech Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable technical indicators, Pharmala Biotech is not utilizing all of its potentials. The recent stock price disturbance, may contribute to mid-run losses for the stockholders.

Pair Trading with Axim Biotechnologies and Pharmala Biotech

The main advantage of trading using opposite Axim Biotechnologies and Pharmala Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Axim Biotechnologies position performs unexpectedly, Pharmala Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pharmala Biotech will offset losses from the drop in Pharmala Biotech's long position.

The idea behind Axim Biotechnologies and Pharmala Biotech Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.